Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0039 | 1 |
Trypanosoma brucei | nucleoside 2-deoxyribosyltransferase | 0.5142 | 1 | 0.5 |
Trypanosoma cruzi | hypothetical protein | 0.5142 | 1 | 0.5 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0067 | 0.0039 | 1 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.007 | 0.0046 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0048 | 0.0001 | 0.0256 |
Echinococcus multilocularis | calpain A | 0.007 | 0.0046 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0001 | 0.0218 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5142 | 1 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0067 | 0.0039 | 0.8502 |
Brugia malayi | calpain family protein 1 | 0.0067 | 0.0039 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.5142 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0039 | 1 |
Echinococcus granulosus | calpain A | 0.007 | 0.0046 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.007 | 0.0046 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.5142 | 1 | 0.5 |
Brugia malayi | calpain family protein 1 | 0.0067 | 0.0039 | 1 |
Trypanosoma cruzi | hypothetical protein | 0.5142 | 1 | 0.5 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.007 | 0.0046 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0001 | 0.0218 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.007 | 0.0046 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.5142 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.